RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy (NCT03524430)

🧪 Interventions in This Study

• Core needle biopsy (PROCEDURE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (7 Sites)

• Siteman Cancer Center — St Louis, Missouri
• Sunnybrook Health Sciences Center — Toronto,
• Institut de Cancerologie de Strasbourg — Strasbourg,
• Universitätsklinikum Münster — Münster,
• SST di Cremona Multidisciplinare di Patologia Mammaria, Italy — Cremona,
• NZOZ Neuromed — Lublin,
• Hospital U. 12 de Octubre — Madrid,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Breast Neoplasm Female

• Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients — New York, New York
• A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2) — Darlinghurst, New South Wales
• Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response — Iowa City, Iowa
• The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI — Washington D.C., District of Columbia

Explore by condition: All Breast Neoplasm Female clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.